ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,297Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 617

$353K Total Retail Price of All Prescriptions

Rank: 189 out of 617

411 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,122 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 547 478 1 4
LEVOTHYROXINE SODIUM 537 502 2 1
HYDROCHLOROTHIAZIDE 446 430 3 13
AMLODIPINE BESYLATE 311 311 4 6
WARFARIN SODIUM 297 295 5 7
SIMVASTATIN 273 273 6 2
CARVEDILOL 263 263 7 19
LISINOPRIL 263 210 7 5
OMEPRAZOLE 261 211 9 3
METFORMIN HCL 251 251 10 9
METOPROLOL SUCCINATE 231 219 11 12
SPIRONOLACTONE 224 194 12 42
POTASSIUM CHLORIDE 213 156 13 10
HYDROCODONE-ACETAMINOPHEN 210 181 S3 14 8
SERTRALINE HCL 204 152 15 20
TRAMADOL HCL 180 111 16 15
METOCLOPRAMIDE HCL 167 131 17 125
METOPROLOL TARTRATE 156 156 18 11
GLIPIZIDE XL 149 149 19 147
ATORVASTATIN CALCIUM 144 138 20 14
GABAPENTIN 127 101 21 16
TAMSULOSIN HCL 120 120 22 26
AMLODIPINE BESYLATE-BENAZEPRIL 115 104 23 80
DETROL LA 104 95 24 127
ALLOPURINOL 101 58 25 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 98 26 29
PREDNISONE 96 90 27 31
RANITIDINE HCL 94 67 28 40
BISOPROLOL-HYDROCHLOROTHIAZIDE 90 87 29 87
METOLAZONE 84 83 30 159
BENAZEPRIL HCL 82 82 31 44
FAMOTIDINE 80 80 32 54
DONEPEZIL HCL 75 75 33 30
CARBIDOPA-LEVODOPA 73 73 34 69
PRAVASTATIN SODIUM 72 72 35 21
ENALAPRIL MALEATE 70 58 36 34
NAMENDA 69 43 37 35
PHENYTOIN SODIUM EXTENDED 68 56 38 121
CRESTOR 68 61 38 28
GLIMEPIRIDE 66 66 40 33
POLYETHYLENE GLYCOL 3350 64 54 41 32
PANTOPRAZOLE SODIUM 61 50 42 37
LANTUS 61 61 42 39
RAMIPRIL 59 59 44 67
GLYBURIDE-METFORMIN HCL 59 59 R 44 157
NEXIUM 57 44 46 43
OXYBUTYNIN CHLORIDE ER 56 32 47 114
TRIAMTERENE-HCTZ 56 56 47 47
CLOPIDOGREL 56 41 47 53
OXYBUTYNIN CHLORIDE 55 55 50 88
FLUTICASONE PROPIONATE 53 43 51 36
DIVALPROEX SODIUM 53 0 51 111
CLONIDINE HCL 52 52 53 55
BYSTOLIC 51 51 54 64
SUCRALFATE 50 49 55 143
ETODOLAC 50 50 55 195
SPIRIVA 50 50 55 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.